Translational biology of osteosarcoma

Cited by (1,000)

Items 501–600 of 1,000

  1. Acetylation dependent functions of Rab22a-NeoF1 Fusion Protein in Osteosarcoma
    Xiaoting Liang, Xin Wang, Yaohui He, Yuanzhong Wu, Li Zhong, Wen Liu, Dan Liao, Tiebang Kang · 2020 · Theranostics
  2. The lncRNA LINC00691 Functions as a ceRNA for miRNA-1256 to Suppress Osteosarcoma by Regulating the Expression of ST5
    Daqian Wan, Yang Qu, Lei Zhang, Songtao Ai, Liming Cheng · 2020 · OncoTargets and Therapy
  3. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma
    Shenglin Wang, Hongxiang Wei, Zhen Huang, Xinwen Wang, Rongkai Shen, Zhaoyang Wu, Jianhua Lin · 2020 · Acta Biochimica et Biophysica Sinica
  4. Osteocytes and Cancer
    Fabrizio Pin, Matthew Prideaux, Lynda Faye Bonewald, Andrea Bonetto · 2021 · Current Osteoporosis Reports
  5. Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?
    Viviana De Martino, Michela Rossi, Giulia Battafarano, Jessica Pepe, Salvatore Minisola, Andrea Del Fattore · 2021 · International Journal of Molecular Sciences
  6. Hypoxia-related microRNA-210 is a diagnostic marker for discriminating osteoblastoma and osteosarcoma
    Scott M. Riester, Jorge Torres‐Mora, Amel Dudakovic, Emily T. Camilleri, Wei Wang, Fuhua Xu, Roman Thaler, Jared M. Evans, René Zwartbol, Inge H. Briaire‐de Bruijn et al. · 2016 · Journal of Orthopaedic Research®
  7. Allosensitization Following Bone Graft
    Eoin Daniel O'Sullivan, Richard K. Battle, Sharon Zahra, John F. Keating, Lorna Marson, David M. Turner · 2017 · American Journal of Transplantation
  8. Permeable Hydrogel Encapsulated Osteosarcoma‐on‐a‐Chip for High‐Throughput Multi‐Drugs Screening
    Haiwen Su, Yuanhai Chen, Zhiyan Xuan, Haoyu Ren, Pei‐Hua Lu, Miaoqing Zhao, Huan Wang · 2025 · Smart Medicine
  9. CDKL3 promotes osteosarcoma progression by activating Akt/PKB
    Aina He, Lanjing Ma, Yujing Huang, Haijiao Zhang, Wei Duan, Zexu Li, Fei Teng, Junqing Yuan, Hao Wu, Liguo Liu et al. · 2020 · Life Science Alliance
  10. Traditional Medicinal Plants as a Source of Inspiration for Osteosarcoma Therapy
    Liliya Kazantseva, José Becerra, Leonor Santos‐Ruiz · 2022 · Molecules
  11. RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway
    Tomoya Takeda, Masanobu Tsubaki, Shuji Genno, Kana Tomita, Shozo Nishida · 2024 · Experimental Cell Research
  12. Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy
    Jacopo Di Gregorio, Laura Di Giuseppe, Sara Terreri, Michela Rossi, Giulia Battafarano, Olivia Pagliarosi, Vincenzo Flati, Andrea Del Fattore · 2024 · Cells
  13. The role of programmed cell death in osteosarcoma: From pathogenesis to therapy
    Suqing Liu, Chengtao Liu, Yian Wang, Jiewen Chen, Yujin He, Kaibo Hu, Ting Li, Junmei Yang, Jie Peng, Liang Hao · 2024 · Cancer Medicine
  14. Using a Family History Questionnaire to Identify Adult Patients with Increased Genetic Risk for Sarcoma
    Alicia Schiavi, J. Lavigne, ROBERT E. TURCOTTE, Lidia Kasprzak, Nadine Dumas, George Chong, Carolyn R Freeman, Mona Alameldin, Polymnia Galiatsatos, Laura Palma et al. · 2015 · Current Oncology
  15. MMP-1 Over-expression Promotes Malignancy and Stem-Like Properties of Human Osteosarcoma MG-63 Cells In Vitro
    Manli Tang, Xiangjun Bai, Yong Li, Xiaojing Dai, Fan Yang · 2018 · Current Medical Science
  16. MiR-92a modulates proliferation, apoptosis, migration, and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3
    Haiyang Yu, Hang Song, Li Liu, Shuo Hu, Yuxin Liao, Gang Li, Xiao Xiao, Xin Chen, Shisheng He · 2019 · Bioscience Reports
  17. Advances in image enhancement for sarcoma surgery
    Bence Baljer, Shivam N. Kolhe, Corey David Chan, Fabio Nicoli, A. Ghanbasha, Marcus J. Brookes, Zakareya Gamie, Kanishka M. Ghosh, Thomas B. Beckingsale, Daniel Bernard Saleh et al. · 2020 · Cancer Letters
  18. Systematic screening for potential therapeutic targets in osteosarcoma through a kinome-wide CRISPR-Cas9 library
    Yuanzhong Wu, Liwen Zhou, Zifeng Wang, Xin Wang, Ruhua Zhang, Lisi Zheng, Tiebang Kang · 2020 · Cancer Biology and Medicine
  19. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody
    Jiaming He, Wenkan Zhang, Tuoyu Di, Jiahong Meng, Yiying Qi, Guoqi Li, Yuxiang Zhang, Hang Su, Weiqi Yan · 2020 · Biomedicine & Pharmacotherapy
  20. Identification of Immune-Related Genes MSR1 and TLR7 in Relation to Macrophage and Type-2 T-Helper Cells in Osteosarcoma Tumor Micro-Environments as Anti-metastasis Signatures
    Zhiyu Chen, Huanhuan Huang, Yang Wang, Fangbiao Zhan, Zhengxue Quan · 2020 · Frontiers in Molecular Biosciences
  21. Deletion of Trp53 and Rb1 in Ctsk‐expressing cells drives osteosarcoma progression by activating glucose metabolism and YAP signaling
    Yang Li, Shuting Yang, Yang Liu, Shuying Yang · 2022 · MedComm
  22. RETRACTED: MicroRNA‐320a inhibits invasion and metastasis in osteosarcoma by targeting cytoplasmic polyadenylation element‐binding protein 1
    Yanlong Wang, Jiyu Yang, Pangtao Chen, Yu Jin Song, Weizheng An, Haoran Zhang, Butegeleqi Butegeleqi, Jinglong Yan · 2020 · Cancer Medicine · Retracted
  23. Sex differences in expression of immune elements emerge in children, young adults and mice with osteosarcoma.
    Mills, Lauren J., Spector, Logan G., Largaespada, David A., Williams, Lindsay A. · 2021 · Biology of Sex Differences
  24. Synthesis of Fe3O4/PDA Nanocomposites for Osteosarcoma Magnetic Resonance Imaging and Photothermal Therapy
    Yifei Zhang, Rende Ning, Wei Wang, Yejin Zhou, Yao Chen · 2022 · Frontiers in Bioengineering and Biotechnology
  25. Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment
    Cassidy M. Van Stiphout, Anita K. Luu, Alicia Viloria‐Petit · 2022 · Cancers
  26. Global research landscape on the crosstalk between ferroptosis and musculoskeletal diseases: A bibliometric and visualized analysis
    Siyang Cao, Yihao Wei, Yaohang Yue, Peng Liu, Hui Zeng · 2023 · Heliyon
  27. G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail
    Zhen Wang, Xiao Chen, Yongqiang Zhao, Yi Jin, Jia Zheng · 2018 · Journal of Cancer Research and Clinical Oncology
  28. Identification of Immune-Related Prognostic Genes and LncRNAs Biomarkers Associated With Osteosarcoma Microenvironment
    Tao Zhang, Yingli Nie, Haifa Xia, Yanbin Zhang, Kailin Cai, Xiangdong Chen, Huili Li, Jiliang Wang · 2020 · Frontiers in Oncology
  29. Combination of ultrathin micro-patterned MXene and PEDOT: Poly(styrenesulfonate) enables organic electrochemical transistor for amperometric determination of survivin protein in children osteosarcoma
    Ping Xu, Chunwen Lu, Dahui Wang, Dong Fu · 2021 · Microchimica Acta
  30. Autophagy-Related Genes and Long Noncoding RNAs Signatures as Predictive Biomarkers for Osteosarcoma Survival
    Jian Zhang, Rui Ding, Tianlong Wu, Jingyu Jia, Xigao Cheng · 2021 · Frontiers in Cell and Developmental Biology
  31. EMMPRIN expression is associated with metastatic progression in osteosarcoma
    Han-Soo Kim, Ha Jeong Kim, Mi Ra Lee, Ilkyu Han · 2021 · BMC Cancer
  32. Nanodelivery Systems Face Challenges and Limitations in Bone Diseases Management
    Federica Giordano, Stefania Lenna, Riccardo Rampado, Ava Brozovich, Takashi Hirase, Mauro G. Tognon, Fernanda Martini, Marco Agostini, Jason Todd Yustein, Francesca Taraballi · 2021 · Advanced Therapeutics
  33. Reversing the pathological microenvironment by radiocatalytic sensitizer for local orthotopic osteosarcoma radiotherapy enhancement
    Kui Chen, Ruyi Zhou, Haojun Liang, You Liao, Shuang Zhu, Xinghua Dong, Yujiao Wang, Sen Liu, Fan Hu, Hao Li et al. · 2022 · Nano Today
  34. Short hairpin RNA (shRNA) of type 2 interleukin-1 receptor (IL1R2) inhibits the proliferation of human osteosarcoma U-2 OS cells
    Xiwei Liu, Li Min, Hong Duan, Rui Shi, Wenli Zhang, Hong Song, Chongqi Tu · 2014 · Medical Oncology
  35. Increased zinc accumulation in mineralized osteosarcoma tissue measured by confocal synchrotron radiation micro X‐ray fluorescence analysis
    Mirjam Rauwolf, Bernhard Pemmer, Andreas Roschger, Anna Turyanskaya, Stephan Smolek, A. Maderitsch, Peter Hischenhuber, Martin Foelser, Rolf Simon, Susanna Lang et al. · 2016 · X-Ray Spectrometry
  36. Primary osteosarcoma in elderly patients: A report of three cases
    Qiang Xu, Tian Gao, Bin Zhang, Jin Zeng, Min Dai · 2019 · Oncology Letters
  37. NGS-analysis to the rescue: dual checkpoint inhibition in metastatic osteosarcoma – a case report and review of the literature
    Nuytemans, Laure, Sys, Gwen, Creytens, David, Lapeire, Lore · 2021 · Acta Clinica Belgica
  38. SPRY4 Intronic Transcript 1 Promotes Epithelial–Mesenchymal Transition Through Association with Snail1 in Osteosarcoma
    Neng Ru, Jie Liang, Fan Zhang, Weifei Wu, Feifan Wang, Xinzong Liu, Yuan-li Du · 2016 · DNA and Cell Biology
  39. Rhizoma Paridis saponins suppresses vasculogenic mimicry formation and metastasis in osteosarcoma through regulating miR-520d-3p/MIG-7 axis
    Nan Yao, Jing Zhou, Yantao Jiang, Qiaomei Jin, He Zhu, Jian Zhang, Zhenlin Li · 2022 · Journal of Pharmacological Sciences
  40. ADCK1 is a potential therapeutic target of osteosarcoma
    Baobiao Zhuo, Lunqing Zhu, Chen Yao, Xi-hua Wang, Shi-xian Li, Rong Wang, Yuan Li, Zhuo‐yan Ling · 2022 · Cell Death and Disease
  41. Aptamer Technology and Its Applications in Bone Diseases
    Xiangzhong Liu, Jing Hu, Yu Ning, Haijia Xu, Hantao Cai, Aofei Yang, Zheng-shuai Shi, Zhanghua Li · 2023 · Cell Transplantation
  42. Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma
    Yiming Zhang, Wenyi Gan, Nan Ru, Zhaowen Xue, Wenjie Chen, Zihang Chen, Huajun Wang, Xiaofei Zheng · 2023 · Journal of bone oncology
  43. miR-137–LAPTM4B regulates cytoskeleton organization and cancer metastasis via the RhoA-LIMK-Cofilin pathway in osteosarcoma
    Ruyu Yan, Dan Liu, Junjie Wang, Minxia Liu, Hongjuan Guo, Jing Bai, Shuo Yang, Jun Chang, Zhihong Yao, Zuozhang Yang et al. · 2023 · Oncogenesis
  44. [Retracted] Circular RNA circHIPK3 Promotes Cell Metastasis through miR‐637/STAT3 Axis in Osteosarcoma
    Zhongyue Huang, Chunyan Yuan, Huijie Gu, Xiangyang Cheng, Kaifeng Zhou, Jun Xu, Xiaofan Yin, Jiangni Xia · 2020 · BioMed Research International · Retracted
  45. Deregulation of CLTC interacts with TFG, facilitating osteosarcoma via the TGF‐beta and AKT/mTOR signaling pathways
    Shi-jie Li, Pan Zhen, Kang Qin, Hua Guo, Yang Qingcheng, Cheng Dongdong · 2021 · Clinical and Translational Medicine
  46. The Effect of Fluid Flow Shear Stress and Substrate Stiffness on Yes-Associated Protein (YAP) Activity and Osteogenesis in Murine Osteosarcoma Cells
    Thomas R. Coughlin, Ali Sana, Kevin Voss, Abhilash Gadi, Upal Basu-Roy, Caroline M. Curtin, Alka Mansukhani, Oran D. Kennedy · 2021 · Cancers
  47. Identification of GPC3 mutation and upregulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target
    Jun‐Hua Nie, Tao Yang, Hong Li, Hai‐Shan Ye, Guo-Qing Zhong, Tingting Li, Chi Zhang, Wenhan Huang, Jin Xiao, Zhi Li et al. · 2021 · Journal of bone oncology
  48. A bone implant with NIR-responsiveness for eliminating osteosarcoma cells and promoting osteogenic differentiation of BMSCs
    Zhuangzhuang Wu, Qiaoqiao Tian, Jiani Wang, Yi Feng, Lizhi Li, Chaojian Xu, Jia Lv, Zhi Lv · 2021 · Colloids and Surfaces B Biointerfaces
  49. N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
    Di Zheng, Ling Yu, Zhun Wei, Kezhou Xia, Weichun Guo · 2022 · Frontiers in Genetics
  50. Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases
    Qinfan Yao, Xiuyuan Zhang, Dajin Chen · 2022 · Frontiers in Oncology
  51. MicroRNA-181a-5p Promotes Osteosarcoma Progression via PTEN/AKT Pathway
    Chen Sun, Chi Chen, Zhen Chen, Jun Guo, Zhi-Hong Yu, Wei Qian, Fen Ai, Liang Xiao, Xiao Guo · 2022 · Analytical Cellular Pathology
  52. Hedgehog signaling orchestrates cartilage-to-bone transition independently of Smoothened
    Huanbo Wang, Chao Zheng, Weiguang Lu, Ting He, Jing Fan, Cheng Wang, Qiang Jie, Danny Tat-Ming Chan, Kathryn S.E. Cheah, Liu Yang · 2022 · Matrix Biology
  53. Charge transfer of ZnTPP/C60 cocrystal-hybridized bioimplants satisfies osteosarcoma eradication with antitumoral, antibacterial and osteogenic performances
    Dongqiong Wang, Wenhan Wang, Hengli Lu, Changwen You, Lei Liang, Chao Liu, Huijing Xiang, Yu Chen · 2022 · Nano Today
  54. A transmembrane protein family gene signature for overall survival prediction in osteosarcoma
    Yuehui Du, Xiaohui Zeng, Weiwei Yu, Wei Xie · 2022 · Frontiers in Genetics
  55. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma
    Jie Wu, Ai Guo, Qiang Li, Difan Wang · 2017 · Future Oncology
  56. Curcumin-encapsulated polymeric nanoparticles for metastatic osteosarcoma cells treatment
    Guanyi Wang, Wantong Song, Na Shen, Haiyang Yu, Mingxiao Deng, Zhaohui Tang, Xueqi Fu, Xuesi Chen · 2017 · Science China Materials
  57. Genetic Polymorphisms of Insulin-Like Growth Factor 1 Are Associated with Osteosarcoma Risk and Prognosis
    Jianshui Mao, Genying Zhuang, Zhikang Chen · 2017 · Medical Science Monitor
  58. Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas
    Ashleigh M. Fordham, Paul G. Ekert, Emmy D.G. Fleuren · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  59. Targeting Irgm1 to combat osteoporosis: suppressing ROS and restoring bone remodeling
    Zichen Cui, Guanghui Gu, Fei Chen, Jianyi Li, Xiaofan Du, Shuqing Chen, Han Zhang, Chenxu Li, Jiale Shao, Jiayi Xi et al. · 2025 · Cell Death and Disease
  60. Long Noncoding RNA LINC00839 Promotes the Malignant Progression of Osteosarcoma by Competitively Binding to MicroRNA-454-3p and Consequently Increasing c-Met Expression
    Yang Zhang, Hai Guo, Li Ma, Xiaoyong Chen, Guangdong Chen · 2020 · Cancer Management and Research · Retracted
  61. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways
    Wendi Zheng, Shuang Li, Jincheng Huang, Yonghui Dong, Hongjun Zhang, Jia Zheng · 2022 · Biological and Pharmaceutical Bulletin
  62. Trifluoperazine activates AMPK / mTOR / ULK1 signaling pathway to induce mitophagy in osteosarcoma cells
    Wenhui Shen, Xiangchen Zeng, Xianhui Zeng, Bao‐Shan Hu, Chong Ren, Zhiming Lin, Long Zhang, Gang Rui, Miersalijiang Yasen, Xiaohui Chen · 2024 · Chemico-Biological Interactions
  63. The RNA binding proteins LARP4A and LARP4B promote sarcoma and carcinoma growth and metastasis
    Coleman, Jennifer C., Tattersall, Luke, Yianni, Val, Knight, Laura, Yu, Hongqiang, Hallett, Sadie R., Johnson, Philip, Caetano, Ana J., Cosstick, Charlie, Ridley, Anne J. et al. · 2024 · iScience
  64. Chalcones induce apoptosis, autophagy and reduce spreading in osteosarcoma 3D models
    Michela Rossi, C. Pellegrino, Martyna Malgorzata Rydzyk, Giovanna Farruggia, Dario de Biase, Silvia Cetrullo, S. D’Adamo, Alessandra Bisi, Paolo Blasi, Emil Malucelli et al. · 2024 · Biomedicine & Pharmacotherapy
  65. Cancer Organoids as reliable disease models to drive clinical development of novel therapies
    Giovanni Blandino, Ronit Satchi‐Fainaro, Ingeborg Tinhofer, Giovanni Tonon, Sarah C. Heilshorn, Yong‐Jun Kwon, Ana Pestana, Carlotta Frascolla, Luca Pompili, Aurora Puce et al. · 2024 · Journal of Experimental & Clinical Cancer Research
  66. Deciphering the role of liquid-liquid phase separation in sarcoma: Implications for pathogenesis and treatment
    Zehao Cheng, Hua Wang, Yibo Zhang, Bolin Ren, Zheng Fu, Zhihong Li, Chao Tu · 2025 · Cancer Letters
  67. Dual mTORC1/2 inhibition by INK-128 results in antitumor activity in preclinical models of osteosarcoma
    Haibin Jiang, Zhiyuan Zeng · 2015 · Biochemical and Biophysical Research Communications
  68. Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin increases the activation of aryl hydrocarbon receptor and is associated with the aggressiveness of osteosarcoma MG-63 osteoblast-like cells
    Shih-Chieh Yang, Chin-Hsien Wu, Yuan-Kun Tu, Shin-Yu Huang, Pai-Chien Chou · 2018 · Oncology Letters
  69. Genetic testing for high-grade osteosarcoma: a guide for future tailored treatments?
    Claudia Maria Hattinger, Maria Pia Patrizio, Elisa Tavanti, Silvia Luppi, Federica Magagnoli, Piero Picci, Massimo Serra · 2018 · Expert Review of Molecular Diagnostics
  70. RETRACTED ARTICLE: Silencing of long noncoding RNA SBF2-AS1 inhibits proliferation, migration and invasion and contributes to apoptosis in osteosarcoma cells by upregulating microRNA-30a to suppress FOXA1 expression
    Jianghua Dai, Wenzhou Huang, Chen Li, Jun Deng, Sijian Lin, Jun Fu Luo · 2019 · Cell Cycle · Retracted
  71. circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma
    Xinyu Tan, Duxun Tan, Haomiao Li, Ye Lin, Zhishen Wen, Canjun Zeng · 2019 · Current Cancer Drug Targets
  72. Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma
    Awf A. Al-Khan, Judith S. Nimmo, Mourad Tayebi, Stewart D. Ryan, James O. Simcock, Raboola Tarzi, Charles A. Kuntz, Eman Saad, Michael J. Day, Samantha J. Richardson et al. · 2020 · Scientific Reports
  73. Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma
    Jiachang Tan, Xiong Qin, Bin Liu, Hao Mo, Zhenjie Wu, Zhenchao Yuan · 2020 · Biomedicine & Pharmacotherapy
  74. A brief overview of antitumoral actions of bruceine D
    Zi Wayne Sin, Vipul Bhardwaj, Amit Kumar Pandey, Manoj Garg · 2020 · Exploration of Targeted Anti-tumor Therapy
  75. Implication of ZNF217 in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K–AKT Signaling for the Treatment of Metastatic Osteosarcoma
    Branden A. Smeester, Garrett M. Draper, Nicholas J. Slipek, Alex T. Larsson, Natalie C. Stratton, Emily J. Pomeroy, Kelsie L. Becklin, Kenta Yamamoto, Kyle Brandon Williams, Kanut Laoharawee et al. · 2020 · Molecular Cancer Therapeutics
  76. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma
    Guo Dai, Gaiwei Liu, Di Zheng, Qi Song · 2021 · European Journal of Pharmacology
  77. Construction and Validation of a Macrophage-Associated Risk Model for Predicting the Prognosis of Osteosarcoma
    Kang-Wen Xiao, Zhibo Liu, Zihang Zeng, Feifei Yan, Lingfei Xiao, Jia-Li Li, Lin Cai · 2021 · Journal of Oncology
  78. Long non‑coding RNA H19 regulates LASP1 expression in osteosarcoma by competitively binding to miR‑29a‑3p
    Hao Jin, Huan Wang, Xin Jin, Wenbo Wang · 2021 · Oncology Reports
  79. VE-822, a novel DNA Holliday junction stabilizer, inhibits homologous recombination repair and triggers DNA damage response in osteogenic sarcomas
    Qikun Yin, Xuecun Liu, Lei Hu, Qinqin Song, Shuqi Liu, Qiuping Huang, Zitong Geng, Yanping Zhu, Xiaopeng Li, Fenghua Fu et al. · 2021 · Biochemical Pharmacology
  80. Involvement of the TGF-β Signaling Pathway in the Development of YAP-Driven Osteosarcoma Lung Metastasis
    Sarah Morice, Geoffroy Danieau, Robel A. Tesfaye, Mathilde Mullard, Régis Brion, Maryne Dupuy, Benjamin Ory, Bénédicte Brounais-Le Royer, Isabelle Corre, Françoise Rédiní et al. · 2021 · Frontiers in Oncology
  81. Sequence Requirements for miR-424-5p Regulating and Function in Cancers
    Jiangying Xuan, Yingxia Liu, Xiaoping Zeng, Hongmei Wang · 2022 · International Journal of Molecular Sciences
  82. Apoptosis-related genes-based prognostic signature for osteosarcoma
    Fei Yang, Yi Zhang · 2022 · Aging
  83. Amino acid metabolism in primary bone sarcomas
    Jennifer A. Jiménez, Elizabeth R. Lawlor, Costas Andreas Lyssiotis · 2022 · Frontiers in Oncology
  84. Comprehensive analysis of potential cellular communication networks in advanced osteosarcoma using single-cell RNA sequencing data
    Ning Xu, Xiaojing Wang, Lili Wang, Yuan Song, Xianyou Zheng, Hai Hu · 2022 · Frontiers in Genetics
  85. A novel strategy combining magnetic particle hyperthermia pulses with enhanced performance binary ferrite carriers for effective in vitro manipulation of primary human osteogenic sarcoma cells
    Antonios Makridis, Magdalini Tziomaki, Konstantina Topouridou, Maria P. Yavropoulou, John G. Yovos, Orestis Kalogirou, Theodoros Samaras, Mavroeidis Angelakeris · 2016 · International Journal of Hyperthermia
  86. Uncarboxylated Osteocalcin Induces Antitumor Immunity against Mouse Melanoma Cell Growth
    Yoshikazu Hayashi, Tomoyo Kawakubo‐Yasukochi, Akiko Mizokami, Mai Hazekawa, Tomiko Yakura, Munekazu Naito, Hiroshi Takeuchi, Seiji Nakamura, Masato Hirata · 2017 · Journal of Cancer
  87. Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood
    Zheng Liu, Jennifer H. Martin, Lisa M. Orme, Beatrice M. Seddon, Jayesh Desai, Wayne Nicholls, Damien B. Thomson, David J.T. Porter, Geoffrey Brian McCowage, Craig R. Underhill et al. · 2018 · Cancer Chemotherapy and Pharmacology
  88. SIRT6 inhibits proliferation and invasion in osteosarcoma cells by targeting N‑cadherin
    Yi Gao, Yuxing Qu, Qi Zhou, Yong Ma · 2018 · Oncology Letters
  89. Transglutaminase-2 promotes metastatic and stem-like phenotypes in osteosarcoma.
    Daniel G. Fuja, Nino Carlo Rainusso, Ryan Lane Shuck, Lyazat Kurenbekova, Lawrence A. Donehower, Jason Todd Yustein · 2018 · Europe PMC (PubMed Central)
  90. Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3
    Yang Zhang, Wenbo Xu, Yanlong Wang, Jianming Li, Guanyi He, Mingyan Guan, Xiangyu Zeng, Wei Bian, Yan Song, Jianyu Liu · 2022 · Bioengineered
  91. The role of long non-coding RNA HCG18 in cancer
    Zhiqiang Wang, Rui Ran, Shunbai Zhang, Wenming Zhou, Jiayang Lv, Chun-Wei Ma, Hai-Hong Zhang · 2022 · Clinical & Translational Oncology
  92. A ferroptosis-related gene signature associated with immune landscape and therapeutic response in osteosarcoma
    Xinxing Wang, Guang Xia, Shilang Xiao, Song Ji Wu, Lina Zhang, Junjie Huang, Wenxiu Zhang, Xu Cao · 2022 · Frontiers in Oncology
  93. LncRNA EBLN3P Facilitates Osteosarcoma Metastasis by Enhancing Annexin A3 mRNA Stability and Recruiting HuR
    Shengtao Wang, Xinxin Zeng, Peng Gui, Shujuan Xu, Zhouqiang Li, Dongxu Chen · 2023 · Annals of Surgical Oncology
  94. Current Advances of Atomically Dispersed Metal-Centered Nanozymes for Tumor Diagnosis and Therapy
    Ruizhen Tian, Yijia Li, Zhengwei Xu, Jiayun Xu, Junqiu Liu · 2023 · International Journal of Molecular Sciences
  95. Temporal chromatin accessibility changes define transcriptional states essential for osteosarcoma metastasis
    William Pontius, Ellen S. Hong, Zachary J. Faber, Jeremy Gray, Craig D. Peacock, Ian Bayles, Katreya Lovrenert, Diana H. Chin, Berkley E. Gryder, Cynthia F. Bartels et al. · 2023 · Nature Communications
  96. Cisplatin and doxorubicin chemotherapy alters gut microbiota in a murine osteosarcoma model
    Zhi Tian, Xiaochen Qiao, Zhichao Wang, Xiaoyan Li, Yongchun Pan, Xiaochun Wei, Zhi Lv, Pengcui Li, Qiujing Du, Wenhao Wei et al. · 2024 · Aging
  97. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment
    Tingxuan Wang, Jincheng Huang, Gang Chen, Jiahui Fu, Tian Li, Xuenong Zou, Hualin Yi · 2024 · International Immunopharmacology
  98. Oncolytic Viral Therapy in Osteosarcoma
    Thomas Karadimas, Thien Huong Huynh, Chloe Chose, Guston Zervoudakis, Bryan A. Clampitt, Sean Lapp, David Michael Joyce, George Douglas Letson, Jonathan L. Metts, Odion T. Binitie et al. · 2024 · Viruses
  99. Targeting DNA Methylation Machinery in Pediatric Solid Tumors
    Camilla Cristalli, Katia Scotlandi · 2024 · Cells
  100. Spatial Heterogeneity of PD-1/PD-L1 Defined Osteosarcoma Microenvironments at Single-Cell Spatial Resolution
    Cheng Hsun Yang, Yan Lai, Juan Wang, Qin Chen, Qilin Pan, Canhua Xu, Pingfan Mo, Guangxiu Guo, Rongchun Chen, Ning Liu et al. · 2024 · Laboratory Investigation